Email ID
Password
Scrip   
Pfizer and UCL to develop stem-cell therapies for macular degeneration
27 April 2009
Sita Shah

Pfizer is to provide funding to University College London (UCL) to develop new stem-cell treatments for age-related macular degeneration (AMD) and other retinal diseases.

The agreement will strengthen Pfizer's position in regenerative medicine, following the launch of its regenerative medicines...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36